Compare COTI (COTI) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
COTI vs Enzyme — how do they compare? COTI trades at Rp201 (market cap Rp581,19M, Rp1,04T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: COTI is far larger — about 4.3× Enzyme's market cap, and COTI's supply is capped (3B / 4,9B COTI (61%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold COTI for 120 Days and Enzyme for 29 Days on average.
| COTI | MLN | |
|---|---|---|
Market Cap | Rp581,19M | Rp134,13M |
Volume (24h) | Rp1,04T | Rp104,56M |
Circulating Supply | 3B / 4,9B COTI (61%) | 3,3M MLN |
Typical Hold Time | 120 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
COTI is trading at Rp199.43 with a bearish technical signal, currently testing support near S1 (Rp176) with oversold RSI hints. The market cap is Rp590.52M with 61% of supply circulating. No major protocol updates were noted recently.
Overall outlook remains cautious due to bearish momentum and limited fundamental catalysts. Key opportunities include potential rebound from oversold levels, while risks involve low liquidity and high volatility typical of small-cap crypto assets.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About COTI
COTI markets itself as the first enterprise-grade fintech platform that empowers organizations to build their own payment solutions as well as digitize any currency to save time as well as money. It is one of the world’s first blockchain protocols that is optimized for decentralized payments and designed for use by merchants, governments, payment DApps, and stablecoin issuers.
Read more on COTI →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
